{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:30:06Z","timestamp":1791412206946,"version":"4.3.3"},"reference-count":33,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/or.2016.4545","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T02:52:39Z","timestamp":1451962359000},"page":"1796-1806","source":"Crossref","is-referenced-by-count":29,"title":["SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis"],"prefix":"10.3892","volume":"35","author":[{"given":"MENGYUAN","family":"YANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIAOHUI","family":"XIE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YILING","family":"DING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,5]]},"reference":[{"key":"key20180107210616_b1-or-35-03-1796","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"key20180107210616_b2-or-35-03-1796","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180107210616_b3-or-35-03-1796","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2174\/1566523214666140825125138","article-title":"SALL4: Engine of cell stemness","volume":"14","author":"Xiong","year":"2014","journal-title":"Curr Gene Ther"},{"key":"key20180107210616_b4-or-35-03-1796","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/msb.2012.65","article-title":"An Oct4-Sall4-Nanog network controls developmental progression in the pre-implantation mouse embryo","volume":"9","author":"Tan","year":"2013","journal-title":"Mol Syst Biol"},{"key":"key20180107210616_b5-or-35-03-1796","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1128\/MCB.00419-10","article-title":"Differential roles of Sall4 isoforms in embryonic stem cell pluripotency","volume":"30","author":"Rao","year":"2010","journal-title":"Mol Cell Biol"},{"key":"key20180107210616_b6-or-35-03-1796","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dvg.20421","article-title":"Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo","volume":"46","author":"Uez","year":"2008","journal-title":"Genesis"},{"key":"key20180107210616_b7-or-35-03-1796","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ncb1481","article-title":"Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1","volume":"8","author":"Zhang","year":"2006","journal-title":"Nat Cell Biol"},{"key":"key20180107210616_b8-or-35-03-1796","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood-2006-02-001594","article-title":"SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice","volume":"108","author":"Ma","year":"2006","journal-title":"Blood"},{"key":"key20180107210616_b9-or-35-03-1796","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1172\/JCI62891","article-title":"A SALL4\/MLL\/HOXA9 pathway in murine and human myeloid leukemogenesis","volume":"123","author":"Li","year":"2013","journal-title":"J Clin Invest"},{"key":"key20180107210616_b10-or-35-03-1796","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00432-014-1808-y","article-title":"SALL4 as a new biomarker for early colorectal cancers","volume":"141","author":"Ardalan Khales","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107210616_b11-or-35-03-1796","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1038\/onc.2013.495","article-title":"SALL4, a novel marker for human gastric carcinogenesis and metastasis","volume":"33","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"key":"key20180107210616_b12-or-35-03-1796","first-page":"1171","article-title":"Oncofetal gene SALL4 in aggressive hepatocellular carcinoma","volume":"369","author":"Masuda","year":"2013","journal-title":"N Engl J Med"},{"key":"key20180107210616_b13-or-35-03-1796","first-page":"933","article-title":"SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer","volume":"38","author":"Kobayashi","year":"2011","journal-title":"Int J Oncol"},{"key":"key20180107210616_b14-or-35-03-1796","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3322\/caac.20113","article-title":"Recent progress in the diagnosis and treatment of ovarian cancer","volume":"61","author":"Jelovac","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107210616_b15-or-35-03-1796","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","article-title":"Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer","volume":"23","author":"Yang","year":"2013","journal-title":"Cancer Cell"},{"key":"key20180107210616_b16-or-35-03-1796","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: New opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107210616_b17-or-35-03-1796","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"key20180107210616_b18-or-35-03-1796","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jmg.40.7.473","article-title":"Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy","volume":"40","author":"Kohlhase","year":"2003","journal-title":"J Med Genet"},{"key":"key20180107210616_b19-or-35-03-1796","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/343821","article-title":"Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family","volume":"71","author":"Al-Baradie","year":"2002","journal-title":"Am J Hum Genet"},{"key":"key20180107210616_b20-or-35-03-1796","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.canlet.2014.11.037","article-title":"SALL4: An emerging cancer biomarker and target","volume":"357","author":"Zhang","year":"2015","journal-title":"Cancer Lett"},{"key":"key20180107210616_b21-or-35-03-1796","first-page":"965","article-title":"Overexpression of SALL4 in lung cancer and its importance in cell proliferation","volume":"26","author":"Kobayashi","year":"2011","journal-title":"Oncol Rep"},{"key":"key20180107210616_b22-or-35-03-1796","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.stem.2012.02.004","article-title":"Functional antagonism between Sall4 and Plzf defines germline progenitors","volume":"10","author":"Hobbs","year":"2012","journal-title":"Cell Stem Cell"},{"key":"key20180107210616_b23-or-35-03-1796","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1447-0756.2011.01798.x","article-title":"Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary","volume":"38","author":"Trinh","year":"2012","journal-title":"J Obstet Gynaecol Res"},{"key":"key20180107210616_b24-or-35-03-1796","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PAS.0000000000000116","article-title":"SALL4 expression in germ cell and non-germ cell tumors: A systematic immunohistochemical study of 3215 cases","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key20180107210616_b25-or-35-03-1796","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bbrc.2006.07.124","article-title":"SALL4 is directly activated by TCF\/LEF in the canonical Wnt signaling pathway","volume":"348","author":"B\u00f6hm","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107210616_b26-or-35-03-1796","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/onc.2011.429","article-title":"Tissue transglutaminase links TGF-\u03b2, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer","volume":"31","author":"Cao","year":"2012","journal-title":"Oncogene"},{"key":"key20180107210616_b27-or-35-03-1796","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/onc.2013.529","article-title":"SALL4 is a new target in endometrial cancer","volume":"34","author":"Li","year":"2015","journal-title":"Oncogene"},{"key":"key20180107210616_b28-or-35-03-1796","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1007\/s00018-012-1122-2","article-title":"EMT-activating transcription factors in cancer: Beyond EMT and tumor invasiveness","volume":"69","author":"S\u00e1nchez-Till\u00f3","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"key20180107210616_b29-or-35-03-1796","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107210616_b30-or-35-03-1796","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1242\/dev.071209","article-title":"Epithelial-mesenchymal transitions: Insights from development","volume":"139","author":"Lim","year":"2012","journal-title":"Development"},{"key":"key20180107210616_b31-or-35-03-1796","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3892\/ijo.2014.2695","article-title":"Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers","volume":"46","author":"Yi","year":"2015","journal-title":"Int J Oncol"},{"key":"key20180107210616_b32-or-35-03-1796","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ygyno.2012.12.018","article-title":"LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer","volume":"128","author":"Chao","year":"2013","journal-title":"Gynecol Oncol"},{"key":"key20180107210616_b33-or-35-03-1796","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2014.10.004","article-title":"The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions","volume":"46","author":"Davidson","year":"2015","journal-title":"Hum Pathol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.4545\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:06:26Z","timestamp":1515341186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.4545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,5]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,1,5]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/or.2016.4545"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.4545","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,5]]}}}